key research & resources .
-
(pub) March 10, 2022
New Study demonstrates Reactivation of Epstein-Barr with elevated IgG-EA antibody levels will eventually develop Rheumatoid Arthritis
-
-
Jan 24, 2022
A new study found that part of the Epstein-Barr virus mimics a protein made in the brain and spinal cord, leading the immune system to mistakenly attack the body’s nerve cells.
-
Jan 25, 2022
Research linking four key risk factors, including reactivated EBV as cause of “long covid”
-
Jan 11, 2022
Phase I clinical trial of Moderna mRNA vaccine for Epstein-Barr virus starting at UMass Chan
-
Early research observes 2/3 of Long COVID patients also have Epstein-Barr Virus Reactivation, indicating strong relationship.
-
-
